You are on Trendlyne United States. Click here to go to India website or make United States as your default

Zoetis Inc - Ordinary Shares - Class A XNYS: ZTS

Zoetis Inc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

151.73 -7.88 (-4.94%)

Near 52W Low of $144.80

3.6M XNYS Volume

XNYS 04 Apr, 2025 5:30 PM (EDT)

Dividend
Zoetis Inc - Ordinary Shares - Class A has an upcoming dividend of $0.50 per share due on 21 Apr 2025 See details

Zoetis Inc - Ordinary Shar... Key Metrics

Default
All financials are in USD Million and price data in USD
VIEW MORE
High Financial Strength
77.8 / 100
Expensive Valuation
19.8 / 100
Technically Bearish
31.6 / 100
Falling Comet These stocks are with good financial quality. But, their bad valuation and technical aspects make the investor think before investing. View Similar Embed DVM

Zoetis Inc - Ordinary Shar... Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '268k10k12kActual RevenueAvg. Estimate
Hit

Zoetis Inc - Ordinary Shares - Class A's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

Current EPS
5.5
Avg. Estimate
5.8
Low Estimate
5.6
High Estimate
6.4
Current EPS
Avg. Estimate
Hit

EPS is expected to grow by 6.2% in FY25

Consensus Recommendation

19 ANALYST Recommendations
BUY

Created with Highcharts 7.2.25Hold4Buy10Strong Buy

The consensus recommendation from 19 analysts for Zoetis Inc - Ordinary Shares - Class A is BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Zoetis Inc - Ordinary Shar... Stock Analysis

Zoetis Inc - Ordinary Shar... stock analysis with key metrics, changes, and trends.

Zoetis Inc - Ordinary Shar... MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$9,256 M8.33%positive

Annual Revenue rose 8.33%, in the last year to $9,256 M. Its sector's average revenue growth for the last fiscal year was 7.48%.

Annual Net Profit$2,486 M6.06%positive

Annual Net Profit rose 6.06% in the last year to $2,486 M. Its sector's average net profit growth for the last fiscal year was -32.26%.

Price to Earning Ratio27.33-negative

Price to Earning Ratio is 27.33, higher than its sector PE ratio of 3.57.

Stock Price$151.73-8.33%negative

Stock Price fell 8.33% and underperformed its sector by 7.61% in the past year.

Quarterly Revenue$2,317 M4.7%positive

Quarterly Revenue rose 4.7% YoY to $2,317 M. Its sector's average revenue growth YoY for the quarter was 5.95%.

Quarterly Net profit$581 M10.67%positive

Quarterly Net profit rose 10.67% YoY to $581 M. Its sector's average net profit growth YoY for the quarter was -47.42%.

Debt to Equity Ratio1.41-negative

Debt to Equity Ratio of 1.41 is higher than 1. This implies that company assets are financed through debt.

Return on Equity(ROE)50.91 %50.91%positive

Return on Equity(ROE) for the last financial year was 50.91%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.

Mutual Fund Holding81.41 %0.63%positive

Mutual Fund Holding increased by 0.63% in the last quarter to 81.41.

Promoter Share Holding0.05 %0.01%positive

Promoter Share Holding increased by 0.01% in the most recent quarter to 0.05%.

Interest Coverage Ratio14.92-positive

Interest Coverage Ratio is 14.92, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding94.19 %0%neutral

Institutional Holding remained the same in the last quarter at 94.19%.

VIEW LESS


Loading data..

Zoetis Inc - Ordinary Shares - Class A - Company Profile

What does Zoetis Inc - Ordinary Shares - Class A do?

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Zoetis Inc - Ordinary Shares - Class A Management structure

All Gross Remunerations are in USD
Ms. Roxanne Lagano
Chief Human Resources Officer, Executive Vice President, Global Operations and Interim General Counsel and Corporate Secretary
-
2024
Gross Remuneration
Year
Ms. Heidi C. Chen
Executive Vice President, General Counsel, Corporate Secretary and Business Lead Lead of Human Health Diagnostics
-
2024
Gross Remuneration
Year
Ms. Wafaa Mamilli
Executive Vice President, Chief Digital Officer and Chief Technology Officer and Group President , China, Brazil and Precision Animal Health
-
2024
Gross Remuneration
Year
Ms. Ester Soria Banque
Executive Vice President and President, U. S. Operations
-
2024
Gross Remuneration
Year
Mr. Keith Sarbaugh
Executive Vice President, Chief Digital Officer and Chief Technology Officer
-
2024
Gross Remuneration
Year
Mr. Jared Shriver
President, U. S. Operations
-
2024
Gross Remuneration
Year

Zoetis Inc - Ordinary Shares - Class A Board of directors

All Gross Remunerations are in USD
Mr. Gavin D.K. Hattersley
Director
-
2024
Gross Remuneration
Year
Dr. Linda Rhodes,PhD
Independent Director
-
2024
Gross Remuneration
Year
Mr. Gregory Norden
Independent Director
-
2024
Gross Remuneration
Year
Ms. Louise M. Parent
Independent Director
-
2024
Gross Remuneration
Year
Mr. Michael B. McCallister
Non-Executive Chairman of the Board
-
2024
Gross Remuneration
Year
Mr. Paul M. Bisaro
Independent Director
-
2024
Gross Remuneration
Year

Zoetis Inc - Ordinary Shares - Class A FAQ

How is Zoetis Inc - Ordinary Shares - Class A today?
Zoetis Inc - Ordinary Shares - Class A today is trading in the red, and is down by -4.94% at 151.73.
Zoetis Inc - Ordinary Shares - Class A is currently trading down -4.94% on an intraday basis. In the past week the stock fell -6.98%. stock has been down -7.09% in the past quarter and fell -8.33% in the past year. You can view this in the overview section.